The Healthtech Times is a weekly newsletter covering healthtech news from Canada and around the globe. Subscribe to H|T using the form at the bottom of this page to ensure you don’t miss out on the most important healthtech news every week!
Whitecap Venture Partners closes $140 million Fund V to invest across Canada (BETAKIT)
Toronto-based Whitecap Venture Partners, which has a portfolio that includes Canadian tech companies like Bolt Logistics and Silofit, has secured $140 million CAD for its fifth fund. Through Fund V, Whitecap plans to expand its geographic investment focus to all of Canada, and allocate more capital towards the seed stage, as it looks to back more B2B software and medtech startups.
Say hello to Pocketed!
Your frictionless grant platform, built to help companies successfully secure grant funding to power their businesses – without diluting. 🤑
We’re reinventing the grant funding game in just three steps: get matched, get financed, get funded! 💸 🚀
Our mission is clear: give entrepreneurs the power to create and build businesses without financial barriers. 💰 💪
Are you ready to access ‘free money’ for your business?
Sign up for your FREE Pocketed account today! 💜
Bright Health banks $750M investment from Cigna Ventures, New Enterprise Associates (FIERCE HEALTHCARE)
Cigna will also bring its expertise in the payer space to support Bright Health’s growth, according to the announcement.
Cross-Border Impact Ventures launches with $30 million in commitments for women, youth-focused healthtech fund (BETAKIT)
CBIV plans to focus primarily on medical device, diagnostic, and digital health firms based in North America, Europe, and Israel, with a secondary eye towards commercial-stage companies in emerging markets that possess “global technology transfer potential.”
SoftBank backs mental health app Cerebral, giving it $4.8B valuation (MED CITY NEWS)
The company recently raised a $300 million funding round led by SoftBank’s second vision fund.
The metrics that show your startup is healthy (BETAKIT)
Mike Kwatinetz of Azure Capital Partners shares his approach to evaluating businesses and how to paint a picture that shows the quality of your startup.
Rebranded Nomic Bio raises $17 million to fuel development of protein-measuring platform (BETAKIT)
According to the Montréal-based startup, “despite decades of technological advances for measuring DNA and RNA,” technologies for measuring proteins “have yet to be scaled.”
Health care startup Nomi Health raises $110M to expand pop-up clinics, payment platform (CRUNCHBASE)
Nomi Health sits outside the box when it comes to traditional health care models in the United States, landing somewhere between health care provider and FinTech startup.
AlayaCare bolsters C-Suite, board to support next phase of growth (BETAKIT)
After securing $225 million CAD in Series D funding this summer, Montréal-based healthtech startup AlayaCare has made a series of new additions to its leadership team, adding some seasoned executives to its C-Suite and board of directors.
Tech panel thinks Canadian startups are ready to move from defence to offence in 2022 (BETAKIT)
In a recent BetaKit Live panel discussion, Shaun Ricci, General Manager, Talent Intelligence at Ceridian Dayforce, Lissa Ricci, Head of Sales, Small Business Solutions at Cisco Canada, and Andrew Popliger, Partner, National Tech Sector Leader at PwC spoke about the changing tides in Canadian tech and explained why talent is at the top of everyone’s mind right now.
Spring Health CEO April Koh on importance of employees’ mental health (BUSINESS INSIDER)
After dozens of employees quit, Spring Health CEO April Koh says she’s now focused on harmonizing hypergrowth with mental health.
Elizabeth Holmes was always in control (THE VERGE)
Control and image are important to Elizabeth Holmes.
How to (successfully) pivot your startup, from a company that did it twice (BETAKIT)
It’s hard to recognize you need a radical course correction. And it’s hard to pull one off once you’ve decided to go for it. We asked a CEO who had two successful pivots to share tips with us.
AbCellera’s antibody treatment becomes first to receive emergency FDA approval for kids under 12 (BETAKIT)
The FDA’s newly expanded Emergency Use Authorization (EUA) for the AbCellera-discovered antibody treatment follows promising clinical trial data, and comes amid ongoing concerns about the Delta and Omicron variants and a youth vaccination push.
Subscribe to The Healthtech Times
Don’t forget to subscribe to The Healthtech Times using the form below to make sure it hits your email inbox every week!
